Transcode Therapeutics reports positive data from the first human clinical study using the novel primary candidate therapy Ttx-Mc138
Transcode Therapeutics报告了首次使用新型主要候选疗法Ttx-Mc138的人体临床研究的积极数据
Transcode Therapeutics reports positive data from the first human clinical study using the novel primary candidate therapy Ttx-Mc138
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.